単純ヘルペスウイルス治療の世界市場インサイト、2030年までの予測Global Herpes Simplex Virus Treatment Market Insights, Forecast to 2030 HSV感染を含む性感染症(STI)の急増は、STI検査・治療の需要を促進している。さらに、性の健康の重要性に対する意識の高まりは、患者が自分の症状を管理し、感染のリスクを軽減しようとするため、HSV治療に対す... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーHSV感染を含む性感染症(STI)の急増は、STI検査・治療の需要を促進している。さらに、性の健康の重要性に対する意識の高まりは、患者が自分の症状を管理し、感染のリスクを軽減しようとするため、HSV治療に対する需要の増加につながっている。このため、HSV感染症に関連するスティグマが減少し、症状の管理と感染リスクの低減に役立つ治療に対する需要が増加している。さらに、発展途上国における医療費の増加は、HSV治療を含む医療サービスへのアクセスを増加させた。これにより、医療へのアクセスが増加し、単純ヘルペスウイルス治療に対する需要が急増した。世界の単純ヘルペスウイルス治療市場は、2024年の1億8,800万米ドルから2030年には2億1,100万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は2.9%になると予測されている。 HSV感染を含む性感染症(STI)の急増が、STI検査・治療の需要を促進している。さらに、性の健康の重要性に対する意識の高まりは、患者が症状を管理し、感染のリスクを軽減しようとするため、HSV治療に対する需要の増加につながっている。このため、HSV感染症に関連するスティグマが減少し、症状の管理と感染リスクの低減に役立つ治療に対する需要が増加している。さらに、発展途上国における医療費の増加は、HSV治療を含む医療サービスへのアクセスを増加させた。このため、医療へのアクセスが増加し、単純ヘルペスウイルス治療の需要が急増した。 レポートの内容 本レポートでは、単純ヘルペスウイルス治療の世界市場、売上、収益、価格の概要を紹介します。2019年~2023年の過去の市場収益/販売データ、2024年の予測、2030年までのCAGR予測による世界市場動向の分析。 単純ヘルペスウイルス治療薬の主要生産者を調査し、主要地域・国の売上高も掲載しています。単純ヘルペスウイルス治療薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点のハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。 本レポートでは、単純ヘルペスウイルス治療薬の売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当て、2019年から2024年までのデータを掲載しています。世界の単純ヘルペスウイルス治療市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。 本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、売上高、収益、価格を分析しています。単純ヘルペスウイルス治療薬の売上高、予測成長動向、生産技術、用途、エンドユーザー産業の評価と市場規模の予測。 Viatris Inc、Abbott Laboratories、Teva Pharmaceutical Industries Ltd、GlaxoSmithKline Plc、Pfizer Inc、Novartis AG、Fresenius SE and Co.KGaA、Amneal Pharmaceuticals LLC、Glenmark Pharmaceuticals Limited、Emcure Pharmaceuticals Limitedなど。 市場セグメンテーション 企業別 ヴィアトリス アボット・ラボラトリーズ テバ・ファーマシューティカル・インダストリーズ社 グラクソ・スミスクライン Plc ファイザー ノバルティスAG フレゼニウスSEおよびCo.KGaA アムニール・ファーマシューティカルズLLC グレンマーク・ファーマシューティカルズ・リミテッド エムキュア・ファーマシューティカルズ・リミテッド タイプ別セグメント アシクロビル バラシクロビル ファムシクロビル 用途別セグメント ドラッグストアおよび小売薬局 オンラインプロバイダー 病院薬局 地域別セグメント 米国およびカナダ 米国 カナダ 中国 アジア(中国を除く) 日本 韓国 中国 台湾 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東、アフリカ、中南米 ブラジル メキシコ トルコ イスラエル GCC諸国 各章の概要 第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。 第2章:単純ヘルペスウイルス治療薬の世界、地域レベル、国レベルでの販売(消費)、収益各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場スペース、生産能力などを紹介しています。 第3章:単純ヘルペスウイルス治療メーカーの競争環境、価格、売上高、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析する。 第4章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。 第5章:読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。 第6章 北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。 第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高、収益。 第8章:中国:タイプ別、用途別、セグメント別の売上高、収益。 第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。 第10章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。 第11章:主要メーカーのプロファイルを提供し、製品の説明と仕様、単純ヘルペスウイルス治療薬の売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。 第12章:産業チェーン、販売チャネル、主要原材料、流通業者と顧客の分析。 第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。 第14章:レポートの要点と結論。 目次1 Study Coverage1.1 Herpes Simplex Virus Treatment Product Introduction 1.2 Market by Type 1.2.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Acyclovir 1.2.3 Valacyclovir 1.2.4 Famciclovir 1.3 Market by Application 1.3.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 Drug Store and Retail Pharmacies 1.3.3 Online Providers 1.3.4 Hospital Pharmacies 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Herpes Simplex Virus Treatment Revenue Estimates and Forecasts 2019-2030 2.2 Global Herpes Simplex Virus Treatment Revenue by Region 2.2.1 Global Herpes Simplex Virus Treatment Revenue by Region: 2019 VS 2023 VS 2030 2.2.2 Global Herpes Simplex Virus Treatment Revenue by Region (2019-2024) 2.2.3 Global Herpes Simplex Virus Treatment Revenue by Region (2025-2030) 2.2.4 Global Herpes Simplex Virus Treatment Revenue Market Share by Region (2019-2030) 2.3 Global Herpes Simplex Virus Treatment Sales Estimates and Forecasts 2019-2030 2.4 Global Herpes Simplex Virus Treatment Sales by Region 2.4.1 Global Herpes Simplex Virus Treatment Sales by Region: 2019 VS 2023 VS 2030 2.4.2 Global Herpes Simplex Virus Treatment Sales by Region (2019-2024) 2.4.3 Global Herpes Simplex Virus Treatment Sales by Region (2025-2030) 2.4.4 Global Herpes Simplex Virus Treatment Sales Market Share by Region (2019-2030) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufacturers 3.1 Global Herpes Simplex Virus Treatment Sales by Manufacturers 3.1.1 Global Herpes Simplex Virus Treatment Sales by Manufacturers (2019-2024) 3.1.2 Global Herpes Simplex Virus Treatment Sales Market Share by Manufacturers (2019-2024) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herpes Simplex Virus Treatment in 2023 3.2 Global Herpes Simplex Virus Treatment Revenue by Manufacturers 3.2.1 Global Herpes Simplex Virus Treatment Revenue by Manufacturers (2019-2024) 3.2.2 Global Herpes Simplex Virus Treatment Revenue Market Share by Manufacturers (2019-2024) 3.2.3 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Treatment Revenue in 2023 3.3 Global Key Players of Herpes Simplex Virus Treatment, Industry Ranking, 2021 VS 2022 3.4 Global Herpes Simplex Virus Treatment Sales Price by Manufacturers (2019-2024) 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Herpes Simplex Virus Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Herpes Simplex Virus Treatment, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Herpes Simplex Virus Treatment, Product Offered and Application 3.8 Global Key Manufacturers of Herpes Simplex Virus Treatment, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Herpes Simplex Virus Treatment Sales by Type 4.1.1 Global Herpes Simplex Virus Treatment Historical Sales by Type (2019-2024) 4.1.2 Global Herpes Simplex Virus Treatment Forecasted Sales by Type (2025-2030) 4.1.3 Global Herpes Simplex Virus Treatment Sales Market Share by Type (2019-2030) 4.2 Global Herpes Simplex Virus Treatment Revenue by Type 4.2.1 Global Herpes Simplex Virus Treatment Historical Revenue by Type (2019-2024) 4.2.2 Global Herpes Simplex Virus Treatment Forecasted Revenue by Type (2025-2030) 4.2.3 Global Herpes Simplex Virus Treatment Revenue Market Share by Type (2019-2030) 4.3 Global Herpes Simplex Virus Treatment Price by Type 4.3.1 Global Herpes Simplex Virus Treatment Price by Type (2019-2024) 4.3.2 Global Herpes Simplex Virus Treatment Price Forecast by Type (2025-2030) 5 Market Size by Application 5.1 Global Herpes Simplex Virus Treatment Sales by Application 5.1.1 Global Herpes Simplex Virus Treatment Historical Sales by Application (2019-2024) 5.1.2 Global Herpes Simplex Virus Treatment Forecasted Sales by Application (2025-2030) 5.1.3 Global Herpes Simplex Virus Treatment Sales Market Share by Application (2019-2030) 5.2 Global Herpes Simplex Virus Treatment Revenue by Application 5.2.1 Global Herpes Simplex Virus Treatment Historical Revenue by Application (2019-2024) 5.2.2 Global Herpes Simplex Virus Treatment Forecasted Revenue by Application (2025-2030) 5.2.3 Global Herpes Simplex Virus Treatment Revenue Market Share by Application (2019-2030) 5.3 Global Herpes Simplex Virus Treatment Price by Application 5.3.1 Global Herpes Simplex Virus Treatment Price by Application (2019-2024) 5.3.2 Global Herpes Simplex Virus Treatment Price Forecast by Application (2025-2030) 6 US & Canada 6.1 US & Canada Herpes Simplex Virus Treatment Market Size by Type 6.1.1 US & Canada Herpes Simplex Virus Treatment Sales by Type (2019-2030) 6.1.2 US & Canada Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 6.2 US & Canada Herpes Simplex Virus Treatment Market Size by Application 6.2.1 US & Canada Herpes Simplex Virus Treatment Sales by Application (2019-2030) 6.2.2 US & Canada Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 6.3 US & Canada Herpes Simplex Virus Treatment Market Size by Country 6.3.1 US & Canada Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030 6.3.2 US & Canada Herpes Simplex Virus Treatment Revenue by Country (2019-2030) 6.3.3 US & Canada Herpes Simplex Virus Treatment Sales by Country (2019-2030) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Herpes Simplex Virus Treatment Market Size by Type 7.1.1 Europe Herpes Simplex Virus Treatment Sales by Type (2019-2030) 7.1.2 Europe Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 7.2 Europe Herpes Simplex Virus Treatment Market Size by Application 7.2.1 Europe Herpes Simplex Virus Treatment Sales by Application (2019-2030) 7.2.2 Europe Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 7.3 Europe Herpes Simplex Virus Treatment Market Size by Country 7.3.1 Europe Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030 7.3.2 Europe Herpes Simplex Virus Treatment Revenue by Country (2019-2030) 7.3.3 Europe Herpes Simplex Virus Treatment Sales by Country (2019-2030) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Herpes Simplex Virus Treatment Market Size by Type 8.1.1 China Herpes Simplex Virus Treatment Sales by Type (2019-2030) 8.1.2 China Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 8.2 China Herpes Simplex Virus Treatment Market Size by Application 8.2.1 China Herpes Simplex Virus Treatment Sales by Application (2019-2030) 8.2.2 China Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Herpes Simplex Virus Treatment Market Size by Type 9.1.1 Asia Herpes Simplex Virus Treatment Sales by Type (2019-2030) 9.1.2 Asia Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 9.2 Asia Herpes Simplex Virus Treatment Market Size by Application 9.2.1 Asia Herpes Simplex Virus Treatment Sales by Application (2019-2030) 9.2.2 Asia Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 9.3 Asia Herpes Simplex Virus Treatment Market Size by Region 9.3.1 Asia Herpes Simplex Virus Treatment Revenue by Region: 2019 VS 2023 VS 2030 9.3.2 Asia Herpes Simplex Virus Treatment Revenue by Region (2019-2030) 9.3.3 Asia Herpes Simplex Virus Treatment Sales by Region (2019-2030) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 9.3.9 Australia 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Type 10.1.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Type (2019-2030) 10.1.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 10.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Application 10.2.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Application (2019-2030) 10.2.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 10.3 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Country 10.3.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030 10.3.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Country (2019-2030) 10.3.3 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Country (2019-2030) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Corporate Profile 11.1 Viatris Inc 11.1.1 Viatris Inc Company Information 11.1.2 Viatris Inc Overview 11.1.3 Viatris Inc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.1.4 Viatris Inc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Viatris Inc Recent Developments 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Information 11.2.2 Abbott Laboratories Overview 11.2.3 Abbott Laboratories Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.2.4 Abbott Laboratories Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Abbott Laboratories Recent Developments 11.3 Teva Pharmaceutical Industries Ltd 11.3.1 Teva Pharmaceutical Industries Ltd Company Information 11.3.2 Teva Pharmaceutical Industries Ltd Overview 11.3.3 Teva Pharmaceutical Industries Ltd Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.3.4 Teva Pharmaceutical Industries Ltd Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Teva Pharmaceutical Industries Ltd Recent Developments 11.4 GlaxoSmithKline Plc 11.4.1 GlaxoSmithKline Plc Company Information 11.4.2 GlaxoSmithKline Plc Overview 11.4.3 GlaxoSmithKline Plc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.4.4 GlaxoSmithKline Plc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 GlaxoSmithKline Plc Recent Developments 11.5 Pfizer Inc 11.5.1 Pfizer Inc Company Information 11.5.2 Pfizer Inc Overview 11.5.3 Pfizer Inc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.5.4 Pfizer Inc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Pfizer Inc Recent Developments 11.6 Novartis AG 11.6.1 Novartis AG Company Information 11.6.2 Novartis AG Overview 11.6.3 Novartis AG Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.6.4 Novartis AG Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Novartis AG Recent Developments 11.7 Fresenius SE and Co. KGaA 11.7.1 Fresenius SE and Co. KGaA Company Information 11.7.2 Fresenius SE and Co. KGaA Overview 11.7.3 Fresenius SE and Co. KGaA Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.7.4 Fresenius SE and Co. KGaA Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Fresenius SE and Co. KGaA Recent Developments 11.8 Amneal Pharmaceuticals LLC 11.8.1 Amneal Pharmaceuticals LLC Company Information 11.8.2 Amneal Pharmaceuticals LLC Overview 11.8.3 Amneal Pharmaceuticals LLC Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.8.4 Amneal Pharmaceuticals LLC Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Amneal Pharmaceuticals LLC Recent Developments 11.9 Glenmark Pharmaceuticals Limited 11.9.1 Glenmark Pharmaceuticals Limited Company Information 11.9.2 Glenmark Pharmaceuticals Limited Overview 11.9.3 Glenmark Pharmaceuticals Limited Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.9.4 Glenmark Pharmaceuticals Limited Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Glenmark Pharmaceuticals Limited Recent Developments 11.10 Emcure Pharmaceuticals Limited 11.10.1 Emcure Pharmaceuticals Limited Company Information 11.10.2 Emcure Pharmaceuticals Limited Overview 11.10.3 Emcure Pharmaceuticals Limited Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.10.4 Emcure Pharmaceuticals Limited Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Emcure Pharmaceuticals Limited Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Herpes Simplex Virus Treatment Industry Chain Analysis 12.2 Herpes Simplex Virus Treatment Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Herpes Simplex Virus Treatment Production Mode & Process 12.4 Herpes Simplex Virus Treatment Sales and Marketing 12.4.1 Herpes Simplex Virus Treatment Sales Channels 12.4.2 Herpes Simplex Virus Treatment Distributors 12.5 Herpes Simplex Virus Treatment Customers 13 Herpes Simplex Virus Treatment Market Dynamics 13.1 Herpes Simplex Virus Treatment Industry Trends 13.2 Herpes Simplex Virus Treatment Market Drivers 13.3 Herpes Simplex Virus Treatment Market Challenges 13.4 Herpes Simplex Virus Treatment Market Restraints 14 Key Findings in the Global Herpes Simplex Virus Treatment Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer
SummaryThe surge in prevalence of sexually transmitted infections (STIs), including HSV infections, is driving demand for STIs testing and treatment. In addition, increase in awareness of the importance of sexual health is leading to increased demand for HSV treatments, as patients seek to manage their symptoms and reduce the risk of transmission. This has reduced the stigma associated with HSV infections and has led to increase in demand for treatments that helps to manage symptoms and reduce the risk of transmission. Furthermore, increase in healthcare expenditure in developing countries has increased access to healthcare services, including HSV treatment. This has increased the access to healthcare and surged the demand for herpes simplex virus treatment. Table of Contents1 Study Coverage1.1 Herpes Simplex Virus Treatment Product Introduction 1.2 Market by Type 1.2.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Acyclovir 1.2.3 Valacyclovir 1.2.4 Famciclovir 1.3 Market by Application 1.3.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 Drug Store and Retail Pharmacies 1.3.3 Online Providers 1.3.4 Hospital Pharmacies 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Herpes Simplex Virus Treatment Revenue Estimates and Forecasts 2019-2030 2.2 Global Herpes Simplex Virus Treatment Revenue by Region 2.2.1 Global Herpes Simplex Virus Treatment Revenue by Region: 2019 VS 2023 VS 2030 2.2.2 Global Herpes Simplex Virus Treatment Revenue by Region (2019-2024) 2.2.3 Global Herpes Simplex Virus Treatment Revenue by Region (2025-2030) 2.2.4 Global Herpes Simplex Virus Treatment Revenue Market Share by Region (2019-2030) 2.3 Global Herpes Simplex Virus Treatment Sales Estimates and Forecasts 2019-2030 2.4 Global Herpes Simplex Virus Treatment Sales by Region 2.4.1 Global Herpes Simplex Virus Treatment Sales by Region: 2019 VS 2023 VS 2030 2.4.2 Global Herpes Simplex Virus Treatment Sales by Region (2019-2024) 2.4.3 Global Herpes Simplex Virus Treatment Sales by Region (2025-2030) 2.4.4 Global Herpes Simplex Virus Treatment Sales Market Share by Region (2019-2030) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufacturers 3.1 Global Herpes Simplex Virus Treatment Sales by Manufacturers 3.1.1 Global Herpes Simplex Virus Treatment Sales by Manufacturers (2019-2024) 3.1.2 Global Herpes Simplex Virus Treatment Sales Market Share by Manufacturers (2019-2024) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herpes Simplex Virus Treatment in 2023 3.2 Global Herpes Simplex Virus Treatment Revenue by Manufacturers 3.2.1 Global Herpes Simplex Virus Treatment Revenue by Manufacturers (2019-2024) 3.2.2 Global Herpes Simplex Virus Treatment Revenue Market Share by Manufacturers (2019-2024) 3.2.3 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Treatment Revenue in 2023 3.3 Global Key Players of Herpes Simplex Virus Treatment, Industry Ranking, 2021 VS 2022 3.4 Global Herpes Simplex Virus Treatment Sales Price by Manufacturers (2019-2024) 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Herpes Simplex Virus Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Herpes Simplex Virus Treatment, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Herpes Simplex Virus Treatment, Product Offered and Application 3.8 Global Key Manufacturers of Herpes Simplex Virus Treatment, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Herpes Simplex Virus Treatment Sales by Type 4.1.1 Global Herpes Simplex Virus Treatment Historical Sales by Type (2019-2024) 4.1.2 Global Herpes Simplex Virus Treatment Forecasted Sales by Type (2025-2030) 4.1.3 Global Herpes Simplex Virus Treatment Sales Market Share by Type (2019-2030) 4.2 Global Herpes Simplex Virus Treatment Revenue by Type 4.2.1 Global Herpes Simplex Virus Treatment Historical Revenue by Type (2019-2024) 4.2.2 Global Herpes Simplex Virus Treatment Forecasted Revenue by Type (2025-2030) 4.2.3 Global Herpes Simplex Virus Treatment Revenue Market Share by Type (2019-2030) 4.3 Global Herpes Simplex Virus Treatment Price by Type 4.3.1 Global Herpes Simplex Virus Treatment Price by Type (2019-2024) 4.3.2 Global Herpes Simplex Virus Treatment Price Forecast by Type (2025-2030) 5 Market Size by Application 5.1 Global Herpes Simplex Virus Treatment Sales by Application 5.1.1 Global Herpes Simplex Virus Treatment Historical Sales by Application (2019-2024) 5.1.2 Global Herpes Simplex Virus Treatment Forecasted Sales by Application (2025-2030) 5.1.3 Global Herpes Simplex Virus Treatment Sales Market Share by Application (2019-2030) 5.2 Global Herpes Simplex Virus Treatment Revenue by Application 5.2.1 Global Herpes Simplex Virus Treatment Historical Revenue by Application (2019-2024) 5.2.2 Global Herpes Simplex Virus Treatment Forecasted Revenue by Application (2025-2030) 5.2.3 Global Herpes Simplex Virus Treatment Revenue Market Share by Application (2019-2030) 5.3 Global Herpes Simplex Virus Treatment Price by Application 5.3.1 Global Herpes Simplex Virus Treatment Price by Application (2019-2024) 5.3.2 Global Herpes Simplex Virus Treatment Price Forecast by Application (2025-2030) 6 US & Canada 6.1 US & Canada Herpes Simplex Virus Treatment Market Size by Type 6.1.1 US & Canada Herpes Simplex Virus Treatment Sales by Type (2019-2030) 6.1.2 US & Canada Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 6.2 US & Canada Herpes Simplex Virus Treatment Market Size by Application 6.2.1 US & Canada Herpes Simplex Virus Treatment Sales by Application (2019-2030) 6.2.2 US & Canada Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 6.3 US & Canada Herpes Simplex Virus Treatment Market Size by Country 6.3.1 US & Canada Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030 6.3.2 US & Canada Herpes Simplex Virus Treatment Revenue by Country (2019-2030) 6.3.3 US & Canada Herpes Simplex Virus Treatment Sales by Country (2019-2030) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Herpes Simplex Virus Treatment Market Size by Type 7.1.1 Europe Herpes Simplex Virus Treatment Sales by Type (2019-2030) 7.1.2 Europe Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 7.2 Europe Herpes Simplex Virus Treatment Market Size by Application 7.2.1 Europe Herpes Simplex Virus Treatment Sales by Application (2019-2030) 7.2.2 Europe Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 7.3 Europe Herpes Simplex Virus Treatment Market Size by Country 7.3.1 Europe Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030 7.3.2 Europe Herpes Simplex Virus Treatment Revenue by Country (2019-2030) 7.3.3 Europe Herpes Simplex Virus Treatment Sales by Country (2019-2030) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Herpes Simplex Virus Treatment Market Size by Type 8.1.1 China Herpes Simplex Virus Treatment Sales by Type (2019-2030) 8.1.2 China Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 8.2 China Herpes Simplex Virus Treatment Market Size by Application 8.2.1 China Herpes Simplex Virus Treatment Sales by Application (2019-2030) 8.2.2 China Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Herpes Simplex Virus Treatment Market Size by Type 9.1.1 Asia Herpes Simplex Virus Treatment Sales by Type (2019-2030) 9.1.2 Asia Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 9.2 Asia Herpes Simplex Virus Treatment Market Size by Application 9.2.1 Asia Herpes Simplex Virus Treatment Sales by Application (2019-2030) 9.2.2 Asia Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 9.3 Asia Herpes Simplex Virus Treatment Market Size by Region 9.3.1 Asia Herpes Simplex Virus Treatment Revenue by Region: 2019 VS 2023 VS 2030 9.3.2 Asia Herpes Simplex Virus Treatment Revenue by Region (2019-2030) 9.3.3 Asia Herpes Simplex Virus Treatment Sales by Region (2019-2030) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 9.3.9 Australia 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Type 10.1.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Type (2019-2030) 10.1.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Type (2019-2030) 10.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Application 10.2.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Application (2019-2030) 10.2.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Application (2019-2030) 10.3 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Country 10.3.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030 10.3.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Country (2019-2030) 10.3.3 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Country (2019-2030) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Corporate Profile 11.1 Viatris Inc 11.1.1 Viatris Inc Company Information 11.1.2 Viatris Inc Overview 11.1.3 Viatris Inc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.1.4 Viatris Inc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Viatris Inc Recent Developments 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Information 11.2.2 Abbott Laboratories Overview 11.2.3 Abbott Laboratories Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.2.4 Abbott Laboratories Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Abbott Laboratories Recent Developments 11.3 Teva Pharmaceutical Industries Ltd 11.3.1 Teva Pharmaceutical Industries Ltd Company Information 11.3.2 Teva Pharmaceutical Industries Ltd Overview 11.3.3 Teva Pharmaceutical Industries Ltd Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.3.4 Teva Pharmaceutical Industries Ltd Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Teva Pharmaceutical Industries Ltd Recent Developments 11.4 GlaxoSmithKline Plc 11.4.1 GlaxoSmithKline Plc Company Information 11.4.2 GlaxoSmithKline Plc Overview 11.4.3 GlaxoSmithKline Plc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.4.4 GlaxoSmithKline Plc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 GlaxoSmithKline Plc Recent Developments 11.5 Pfizer Inc 11.5.1 Pfizer Inc Company Information 11.5.2 Pfizer Inc Overview 11.5.3 Pfizer Inc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.5.4 Pfizer Inc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Pfizer Inc Recent Developments 11.6 Novartis AG 11.6.1 Novartis AG Company Information 11.6.2 Novartis AG Overview 11.6.3 Novartis AG Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.6.4 Novartis AG Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Novartis AG Recent Developments 11.7 Fresenius SE and Co. KGaA 11.7.1 Fresenius SE and Co. KGaA Company Information 11.7.2 Fresenius SE and Co. KGaA Overview 11.7.3 Fresenius SE and Co. KGaA Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.7.4 Fresenius SE and Co. KGaA Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Fresenius SE and Co. KGaA Recent Developments 11.8 Amneal Pharmaceuticals LLC 11.8.1 Amneal Pharmaceuticals LLC Company Information 11.8.2 Amneal Pharmaceuticals LLC Overview 11.8.3 Amneal Pharmaceuticals LLC Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.8.4 Amneal Pharmaceuticals LLC Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Amneal Pharmaceuticals LLC Recent Developments 11.9 Glenmark Pharmaceuticals Limited 11.9.1 Glenmark Pharmaceuticals Limited Company Information 11.9.2 Glenmark Pharmaceuticals Limited Overview 11.9.3 Glenmark Pharmaceuticals Limited Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.9.4 Glenmark Pharmaceuticals Limited Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Glenmark Pharmaceuticals Limited Recent Developments 11.10 Emcure Pharmaceuticals Limited 11.10.1 Emcure Pharmaceuticals Limited Company Information 11.10.2 Emcure Pharmaceuticals Limited Overview 11.10.3 Emcure Pharmaceuticals Limited Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024) 11.10.4 Emcure Pharmaceuticals Limited Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Emcure Pharmaceuticals Limited Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Herpes Simplex Virus Treatment Industry Chain Analysis 12.2 Herpes Simplex Virus Treatment Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Herpes Simplex Virus Treatment Production Mode & Process 12.4 Herpes Simplex Virus Treatment Sales and Marketing 12.4.1 Herpes Simplex Virus Treatment Sales Channels 12.4.2 Herpes Simplex Virus Treatment Distributors 12.5 Herpes Simplex Virus Treatment Customers 13 Herpes Simplex Virus Treatment Market Dynamics 13.1 Herpes Simplex Virus Treatment Industry Trends 13.2 Herpes Simplex Virus Treatment Market Drivers 13.3 Herpes Simplex Virus Treatment Market Challenges 13.4 Herpes Simplex Virus Treatment Market Restraints 14 Key Findings in the Global Herpes Simplex Virus Treatment Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(virus)の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |